- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
Carbamoyl phosphate synthetase 1 (CPS1), also referred to as CPSase I, is a mitochondrial enzyme that catalyzes the first and rate-limiting step of the urea cycle, converting ammonia into carbamoyl phosphate within hepatocytes. CPSase I Antibody / Urea Cycle Enzyme CPS1 Antibody is used to study this critical metabolic pathway, with particular relevance to ammonia detoxification and nitrogen metabolism in liver tissue. CPS1 antibody, also known as Carbamoyl phosphate synthetase 1 antibody in the literature, is widely utilized in research focused on hepatic metabolism and mitochondrial enzyme function.
CPS1 is localized to the mitochondrial matrix of hepatocytes, where it initiates the urea cycle by incorporating free ammonia into carbamoyl phosphate. This reaction is essential for preventing toxic accumulation of ammonia in the bloodstream. As a central enzyme in nitrogen metabolism, CPS1 plays a key role in maintaining metabolic homeostasis, particularly under conditions of increased protein catabolism. Its activity is tightly regulated and dependent on allosteric activation by N-acetylglutamate, further highlighting its importance in coordinated metabolic control.
Expression of CPS1 is largely restricted to hepatocytes, making it a valuable marker for liver-specific metabolic function. In immunohistochemistry, CPS1 is typically detected as strong cytoplasmic staining in hepatocytes, consistent with its mitochondrial localization, while non-hepatic tissues show minimal expression. This restricted distribution supports its use in studies examining liver physiology, metabolic zonation, and hepatocyte differentiation.
Functionally, CPS1 serves as the entry point to the urea cycle, linking nitrogen metabolism to energy balance and amino acid turnover. Disruption of CPS1 activity is associated with urea cycle disorders, hyperammonemia, and liver dysfunction. CPS1 antibody is therefore commonly used in investigations of metabolic disease, inherited enzyme deficiencies, and hepatic injury. Its role in mitochondrial metabolism also makes it relevant to studies of cellular energetics and organ-specific metabolic regulation.
In addition to its physiological role, CPS1 expression is often evaluated in the context of liver pathology, including hepatocellular carcinoma and other hepatic disorders. Retention of CPS1 expression in tumor cells can provide insight into hepatocellular origin and metabolic state. The ability to detect CPS1 reliably in tissue sections and biochemical assays supports its continued use in both basic and translational research settings.
CPSase I Antibody provides consistent detection of CPS1 in applications such as immunohistochemistry and western blot, enabling detailed analysis of urea cycle enzyme expression. Its use in studies of nitrogen metabolism, liver function, and mitochondrial biology makes it a valuable tool for understanding the biochemical pathways that regulate ammonia detoxification and metabolic homeostasis.
For a validated reference of CPS1 expression in liver and hepatocellular tumors, see the CPS1 antibody clone CPS1/9859 with supporting IHC and western blot data.
Optimal dilution of the CPSase I Antibody / Urea Cycle Enzyme CPS1 Antibody should be determined by the researcher.
A portion of amino acids 800-100 from human CPS1 protein was used as the immunogen for the CPSase I antibody.
Aliquot the CPSase I antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
CPS1 antibody, Carbamoyl phosphate synthetase 1 antibody, CPSase I antibody, Urea cycle enzyme antibody, Mitochondrial CPS1 antibody
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.